Corebridge Financial’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-49,714
Closed -$353K 1840
2025
Q1
$353K Sell
49,714
-737
-1% -$5.24K ﹤0.01% 1770
2024
Q4
$588K Sell
50,451
-1,063
-2% -$12.4K ﹤0.01% 1591
2024
Q3
$1.06M Sell
51,514
-317
-0.6% -$6.51K 0.01% 1332
2024
Q2
$1.16M Buy
+51,831
New +$1.16M 0.01% 1256